INTRODUCTION
============

Obstructive sleep apnea syndrome (OSAS), which is caused by a complete or partial obstruction of the upper airway producing apnea or hypopnea, is a sleep disorder characterized by repetitive cessation of breathing occurring during sleep \[[@B1]\]. According to the American Academy of Sleep Medicine, a diagnosis of OSAS can be made in the presence of five or more episodes of apnea/hypopnea per hour of sleep, accompanied by clinical symptoms (such as daytime sleepiness, mood disorder, insomnia, hypertension), or at least 15 events per hour without additional symptoms. OSAS is defined as mild when characterized by 5 - 15 events per hour, moderate in the presence of up to 30 events per hour, and severe when these number more than 30 \[[@B2]\].

The pathogenesis of OSAS is multifactorial, however two main categories are described in the literature that, in some cases, can occur in combination. The first, and more common, form is due to obstruction of the respiratory lumen, for example at the level of the retropalatal and retroglossal spaces, involving the soft palate and the base of the tongue \[[@B3]\]. This obstruction, which can be partial or total, is linked to tissue factors such as tonsillar hypertrophy, but also to obesity, which can determine fatty infiltration of the pharyngeal wall \[[@B4],[@B5]\]. The second, less frequent form is central OSAS, which is due to dysfunction of the cerebral mechanisms that control the pharyngeal muscles that keep the airways open during sleep. In this case, suppression of nerve impulses results in a narrower airspace that is more prone to collapsing on inspiration during sleep \[[@B6]\]. Certain skeletal abnormalities, such as reduced sagittal linear dimensions of the cranial base, of the maxilla, and also of the bony naso-oropharynx, can also predispose to OSAS. Retrognathia of both the maxilla and the mandible and increased lower face height frequently show a bold relationship with OSAS \[[@B7]\]. In addition, in OSAS subjects the hyoid bone is located more inferiorly, between the fourth and the sixth cervical vertebra, and the intermaxillary space length (the distance between the posterior pharyngeal wall and the tip of the lower incisor) is reduced. These alterations decrease the tongue space, causing it to lie in a lower and a more posterior position, where it causes partial or total obstruction of the pharyngeal lumen during sleep \[[@B8]\]. Due to repeated apnea/hypopnea episodes, OSAS patients have disturbed and less restorative sleep, and thus present several characteristic symptoms, such as daytime sleepiness associated with a higher risk of motor vehicle accidents, morning headache, mood disorder, depression and lack of libido \[[@B9],[@B10]\]. They also have an increased incidence of medical comorbidities (e.g. hypertension, stroke, death) \[[@B11]\].

In the initial therapeutic approach, OSAS patients are encouraged to make lifestyle changes, for instance, to lose weight (in the case of obese patients), but also to stop using alcohol or other agents that can facilitate collapse of the upper airway. However, the main therapeutic options also include continuous positive airway pressure (C-PAP) therapy, oral appliances and surgical procedures \[[@B12]\]. C-PAP therapy is based on the maintenance of constant air pressure, preventing the collapse of the upper airway during sleep, and it is recommended for subjects with an upper airway obstruction. It is currently the gold standard non-invasive treatment for OSAS, but it is not indicated in patients with nasal obstruction or claustrophobia \[[@B13],[@B14]\]. The CPAP machine is quite voluminous and it must be used every night; this treatment has a high therapeutic efficacy but it is poorly tolerated and refused by 50% of patients \[[@B13]\]. Other therapeutic strategies are the use of oral mandibular repositioning appliances, usually better tolerated by patients, but successful only in the treatment of mild-to-moderate cases of sleep apnea. These appliances cover the upper and lower teeth and hold the mandible in an advanced position, thus widening the upper airway \[[@B14]\].

Surgical therapy includes a variety of upper airway reconstructive or skeletal procedures. Surgical modifications of the soft tissue of the upper airway - e.g. uvulopalatopharyngoplasty (UPPP), partial midline glossectomy and radiofrequency volumetric tissue reduction - were, in the past, commonly used to increase the posterior airway space in severe OSAS \[[@B15]\]. Orthognathic surgical procedures, on the other hand, consist of: anterior inferior mandibular sagittal osteotomy (genioglossal advancement), which, together with hyoid suspension, constitutes phase I surgery, genioplasty, and maxillomandibular advancement osteotomies \[[@B15]\]. Maxillomandibular advancement (MMA) is used for OSAS patients with dentofacial deformities requiring orthognathic surgery and/or for those with extremely severe obstructive disease, in whom all applicable conservative therapies have failed or proved intolerable \[[@B16]\]. MMA is the most effective surgical therapy for OSAS \[[@B13],[@B17]\]. It consists of Le Fort I osteotomy of the maxilla and a bilateral sagittal split osteotomy of the mandible producing simultaneous advancement of both the maxilla and the mandible, and of the soft tissue overlying these structures. This procedure, by modifying the pharyngeal structures and the tongue space, increases the dimension of the upper airway and thus reduces the risk of pharyngeal collapse during negative pressure inspiration \[[@B18],[@B19]\]. This method is sometimes associated with anticlockwise rotation of the occlusal plane that advances the soft palate \[[@B20]\]. Recently Li \[[@B21]\] reported a success rate of 89%, and Prinsell \[[@B22]\], too, demonstrated that MMA is a highly effective treatment with a success rate of between 86.5% and 86.6%. For this reason it can be considered the surgical treatment of choice that is able, especially when performed in young patients, to significantly improve the quality of life of individuals with OSAS. This study set out to evaluate the effects of MMA on OSAS patients treated with orthognathic surgery; specifically, its aim was to establish which cephalometric variables can influence changes in respiratory symptoms.

MATERIAL AND METHODS
====================

This retrospective study analyzed 15 patients (11 males and 4 females) from an initial pool of 27 patients ( [Table 1](#T1){ref-type="table"} , who had clinical and polysomnographic evidence of moderate (1 subject) or severe (14 subjects) OSAS and were submitted to orthognathic surgery as detailed in [Table 2](#T2){ref-type="table"} . The mean age of the 15 patients who underwent MMA was 42.3 ± 9.5 years (range from 26.3 to 62.5 years). On the basis of ANB, nine patients were deemed to have presurgical skeletal Class II malocclusion (ANB \> 4°), five patients Class I malocclusion (ANB = 2° ± 2°), and only one patient Class III (ANB \< 0°) malocclusion. All the patients had already undergone other non-invasive treatments that had been unsuccessful (oral appliances) or had been rejected in the long term (C-PAP). All were medically stable enough to undergo orthognathic surgery. All the subjects included in this study were adults referred from the Department of Maxillofacial Surgery of the Sant\'Anna Hospital in Como, Italy. Each patient was evaluated with nocturnal polysomnoraphy (PSG) and lateral cephalometric radiographs preoperatively (T1) and after the surgery (T2). All underwent orthodontic treatment in parallel with surgery. The variables taken into account were: age, gender, apnea/hypopnea index (AHI), lowest oxygen saturation (LSAT) level, and cephalometric data.

###### 

Selection and exclusion criteria used to recruit OSAS patients

  Sample selection                   No. of OSAS patients
  ---------------------------------- ----------------------
  **Patient sample**                 27
  1\. Incomplete records             8
  2\. Poor film quality              3
                                     
  **Secondary exclusion criteria**   
  3\. Use of concomitant C-PAP       1
                                     
  **Final sample**                   15

C-PAP = continuous positive airway pressure therapy.

**Polysomnography**

PSG was performed at the Sleep center of the San Raffaele Hospital in Milan and at the Department of Sleep Medicine of the Felice Villa Hospital in Mariano Comense (Co) using a SomnoCheck Effort polygraph (Weinmann, Hamburg, Germany). The following variables were measured for each patient: AHI, as measure of therapeutic efficacy, and LSAT. These variables were used to determine the presence and severity of OSAS before surgery and to establish (on the basis of changes in the PSG variables after surgery) the clinical effectiveness of the therapy.

**Cephalometric analysis**

Pre- and postoperative lateral cephalometric radiographs for each patient were taken with the teeth in occlusion and following a standardized procedure. The cephalometric examination was carried out with a standardization of the magnification factor, and each cephalogram was double hand-traced by two different investigators who were unaware of the clinical results. The landmarks used in this study are shown in [Figure 1](#fig1){ref-type="fig"} . The following linear and angular variables were analyzed: SNA (angle between the sella, nasion and subspinale point A), SNB (angle between the sella, nasion and supramentale point B), ANB (angle between the maxilla and the mandible), PAS (the narrowest distance between the base of the tongue and the posterior pharyngeal wall -- a measurement used to detect pharyngeal obstruction), MP-H (distance from the mandibular plane to the most anterior point of the hyoid bone), Co-A (the amount of maxillary advancement) and Co-Pog (the amount of mandibular advancement).

![Cephalometric variables measured:\
1 = SNA (angle between sella, nasion and subspinale point A);\
2 = SNB (angle between sella, nasion and supramentale point B);\
3 = ANB (angle between the maxilla and the mandible);\
4 = PAS (the narrowest distance between the base of the tongue and the posterior pharyngeal wall);\
5 = MP-H (distance from the mandibular plane to the most anterior point of the hyoid bone);\
6 = Co-A (amount of the maxillary advancement);\
7 = Co-Pog (amount of mandibular advancement).](jomr-04-e5-g001){#fig1}

**Surgical procedure**

The surgical procedure consisted of Le Fort I advancement and bilateral mandibular sagittal split osteotomies ( [Figure 2](#fig2){ref-type="fig"} , [Figure 3A](#fig3A){ref-type="fig"} , [B](#fig3B){ref-type="fig"} ). Rigid fixations were used in all patients to hold the bones in their new position: microplates at the maxilla and miniplates with monocortical screws at the mandible (Synthes CMF, Missisauga, Ontario, Canada). No patient underwent maxillomandibular fixation, but all underwent advancement genioplasty according to Prinsell \[[@B23]\]. The postsurgical assessment was performed within one year of surgery. It consisted of a clinical follow-up, a radiological evaluation with orthopantomography and lateral cephalometric radiographs, and a PSG assessment. MMA, whose amount depended on the initial craniofacial characteristics, was evaluated in each patient.

![Mandibular advancement.](jomr-04-e5-g002){#fig2}

![Bimaxillary advancement (frontal view).](jomr-04-e5-g003A){#fig3A}

![Bimaxillary advancement (profile view).](jomr-04-e5-g003B){#fig3B}

**Statistical analysis**

Descriptive statistical analysis was performed for all demographic variables (age and gender) and outcome variables at T1 and T2. The Wilcoxon signed rank test was used to determine the correlation between the PSG variables and the cephalometric variables for each outcome measure, and P \< 0.05 was considered statistically significant for all analyses. In addition, pre- versus postoperative reduction in the AHI was calculated to establish the treatment effectiveness.

**Method error**

Each radiograph was traced by two different operators at different times. Application of the paired t-test revealed no significant mean differences between the two series of records. Dalhberg\'s formula was used to assess the method error \[[@B24]\]. Errors were normally less than one unit, ranging from 0.2 to 0.8 mm for linear measurements and from 0.4° to 1° for angular measurements, corresponding of a coefficient of reliability of 96% \[[@B25]\].

RESULTS
=======

**Effect of MMA on OSAS**

[Table 2](#T2){ref-type="table"} shows preoperative and postoperative AHI and LSAT values with corresponding percentage changes. Postoperatively, the overall mean AHI dropped from 58.7 ± 16 to 8.1 ± 7.8 events per hour (P \< 0.001). The mean preoperative LSAT increased from 71% preoperatively to 90% after surgery (P \< 0.001).

###### 

Pre- and postoperative polysomnographic recordings

  Patient No.   Sex   AHI    LSAT         
  ------------- ----- ------ ------ ----- -----
  **1**         M     31     3      87%   93%
  **2**         M     44     7      79%   90%
  **3**         M     57     11     62%   82%
  **4**         M     69     4      83%   92%
  **5**         M     70     5      76%   88%
  **6**         F     79     30     62%   88%
  **7**         F     62     4      66%   73%
  **8**         M     25     3      80%   89%
  **9**         F     73     4      84%   84%
  **10**        M     60     4      78%   85%
  **11**        M     51     5      69%   91%
  **12**        M     70     3      56%   92%
  **13**        M     71     22     62%   77%
  **14**        F     48     8      85%   86%
  **15**        M     70     8      79%   88%
  **Mean**      \-    58.7   8.1    71%   90%

AHI = Apnea/hypopnea index; LSAT = lowest oxygen saturation; M = male; F = female.

**Cephalometric analysis**

Lateral cephalometric radiographic evaluation ( [Table 3](#T3){ref-type="table"} ) showed mean preoperative SNA and SNB values of 79.9° ± 5.8° and 74.3° ± 4.9° respectively; the mean postoperative values were 85.9° ± 5.8° and 78.5° ± 5.0°, respectively. The mean overall amount of maxillary advancement measured on X-ray was 5.2 mm (± 4.5 mm), ranging from 0 mm to 14 mm. The mean amount of mandibular advancement measured on X-ray was 9.5 mm (± 8.7 mm), ranging from - 2 to 29 mm. Postoperative cephalometric analysis ( [Table 4](#T4){ref-type="table"} ) showed a statistically significant average variation (P = 0.01) of the SNA which correlated with the decrease in the AHI. The mean SNA variation was 6° (falling from 79.9° ± 5.8° to 85.9° ± 5.8°). In addition, the increase in LSAT was found to show a statistically significant correlation both with the amount of maxillary advancement (P = 0.03) and with the amount of mandibular advancement (P = 0.029). In particular, the results show that for each mm of Co-A and Co-Pog increase there was a 1% increase in LSAT. No statistically significant correlations were found between the PSG parameter AHI and the SNB (P = 0.07), ANB (P = 0.33), PAS (P = 0.74) and MP-H (P = 0.16). The position of the hyoid was recorded in relation to the mandible, and the mean distance from the hyoid to the mandible plane was increased by 1.3 mm (from 28.2 mm to 29.5 mm) on the post-treatment X-ray. This change was not statistically significant. The PAS increased from 5 ± 2.2 mm to 9.5 ± 3.3 mm.

###### 

Differences between preoperative and postoperative cephalometric values and means of differences

               Preoperative   Postoperative   Mean of difference                
  ------------ -------------- --------------- -------------------- ------ ----- -----
  **SNA**      79.9           4.3             85.9                 8.5    6     3.2
  **SNB**      74.3           4.9             78.5                 5      4.2   2.2
  **ANB**      5.6            2.9             7.4                  2.1    1.8   3.8
  **PAS**      5              2.2             9.5                  3.3    4.4   3.7
  **MP-H**     28.2           5.4             29.5                 5.8    1.3   2.5
  **Co-A**     86.9           9.9             92.2                 11.3   5.2   4.5
  **Co-Pog**   119            15              126.5                14.3   9.5   8.7

SNA = angle between sella, nasion and subspinale point A; SNB = angle between sella, nasion and supramentale point B; ANB = angle between the maxilla and the mandible; PAS = the narrowest distance between the base of the tongue and the posterior pharyngeal wall; MP-H = distance from the mandibular plane to the most anterior point of the hyoid bone); Co-A = amount of the maxillary advancement; Co-Pog = amount of the mandibular advancement; SD = standard deviation.

###### 

Correlation between polysomnographic and cephalometric variables

  Parameter                                  Correlation with AHI   P-value^a^   Correlation with LSAT   P-value^a^
  ------------------------------------------ ---------------------- ------------ ----------------------- ------------
  **Cephalometric variables**                                                                            
  **SNA**                                    \- 0.62                0.01         0.18                    0.53
  **SNB**                                    \- 0.48                0.07         0.13                    0.27
  **ANB**                                    \- 0.27                0.33         0.33                    0.22
  **PAS**                                    \- 0.09                0.74         0.38                    0.16
  **MP-H**                                   \- 0.38                0.16         0.03                    0.89
                                                                                                         
  **Maxillary and mandibular advancement**                                                               
  **Co-A**                                   \- 0.24                0.39         \- 0.57                 0.03
  **Co-B**                                   \- 0.09                0.74         \- 0.61                 0.02

^a^P \< 0.05 was considered statistically significant for all analyses. Wilcoxon signed rank test was used to determine the correlation between the PSG variables and the cephalometric variables for each of the outcome measures.

AHI = Apnea/hypopnea index; LSAT = lowest oxygen saturation; SNA = angle between sella, nasion and subspinale point A; SNB = angle between sella, nasion and supramentale point B; ANB = angle between the maxilla and the mandible; PAS = narrowest distance between the base of the tongue and the posterior pharyngeal wall; MP-H = distance from the mandibular plane to the most anterior point of the hyoid bone; Co-A = amount of maxillary advancement; Co-Pog = amount of mandibular advancement.

DISCUSSION
==========

This study set out to identify what pre- and postoperative cephalometric characteristics might help predict an OSAS patient\'s response to MMA and also which outcome variables might predict a higher success rate. As shown in the previous OSA surgical literature \[[@B13]\], success corresponds to an AHI of less than 20 and/or an at least 50% reduction of AHI from the preoperative level. On this basis, the therapy could be deemed successful in all the 15 patients undergoing MMA in our study (13 had an AHI \< 20 after surgery and the other two recorded a 50% reduction).

Comparison of the pre- and postoperative PSG results showed a clear improvement in all patients after MMA surgery. Albeit in a small sample, we therefore recorded a 100% success rate of MMA, which is similar to the findings of previous studies which reported success rates ranging from 95% to 98% \[[@B21],[@B26]\]. In accordance with the findings of a recent meta-analysis led by Holty and Guilleminaul \[[@B13]\], the mean overall LSAT level increased from 71% to 90%. The results of the present study also showed a statistically significant increase in the SNA in all the successfully treated cases (P = 0.01). This implies that the improvement in a patient\'s respiratory symptomatology is affected by the amount of SNA increase. As reported in several publications \[[@B22]\], bimaxillary advancement surgery has been successfully used to correct craniofacial skeletal anomalies in OSAS patients, inducing a regression of the syndrome. Nevertheless, some authors \[[@B27],[@B28]\] concluded that MMA can be considered a treatment option in OSAS patients without cephalometrically defined maxillomandibular deficiency; it has been shown to be a successful therapeutic option for moderate or severe OSAS patients even in absence of skeletal and\\or occlusal anomalies. In this study, nine patients had presurgical skeletal Class II malocclusion (ANB \> 4°), five patients Class I malocclusion (ANB = 2° ± 2°), and only one patient Class III (ANB \< 0°) malocclusion. A comparable study of a population of 82 OSAS patients found that only one-third were diagnosed as skeletal Class II, 60% as Class I and 10% as Class III \[[@B29]\]. The surgical correction of our Class III patient resulted in less anterior movement of the mandible than is typical in MMA surgery. Although the mandibular advancement in this patient was only 3 mm, the AHI decreased from 44 to 7 events per hour, thus confirming that MMA surgery is indicated not only in Class II, but also in Class I and in Class III malocclusion, as previously demonstrated by others \[[@B15]\].

Other recent studies, moreover, have pinpointed characteristics useful for identifying which patients might benefit from MMA. One of these characteristics is the presence of pharyngeal narrowing in the basal lingual area with retrognathia, especially when the length of the PAS at the level of the mandibular base is less than 11 mm \[[@B30]\] or less than 9 mm \[[@B22]\] and the SNB is less than 77°. Hochban and Brandenburg \[[@B31]\] suggest other traits based on cephalometric measurements, such as pharyngeal narrowing in combination with a retrognathic or dolicofacial profile. Holty and Guilleminault \[[@B13]\], through a systematic review and a meta-analysis including 627 OSAS adults, found that no pre- or postoperative cephalometric measurements, with the exception of a wider PAS, were predictive of successful MMA surgery. The only predictive factors noted were the degree of maxillary advancement, similar to our own findings, in association with a lower preoperative body mass index, young age and female gender. Our findings confirm that mandibular movement does not influence the response to MMA. Instead, it is the change in SNA that determines the improvement in the respiratory symptoms. In our study the mandibular plane to hyoid bone distance did not show a significant change, thus supporting the findings of Gale at al. \[[@B32]\]. The width of the PAS was measured as the narrowest distance between the base of the tongue and the posterior pharyngeal wall, which is not related to any skeletal structures \[[@B33]\]. This value increased from 5 ± 2.2 mm to 9.5 ± 3.3 mm, replicating the findings of other studies \[[@B13]\] and thus demonstrating that the dimension of the airway increased after surgery.

CONCLUSIONS
===========

Several published data support bimaxillary advancement as the most effective available surgical option for treating OSA patients; therefore MMA may be considered, in certain cases, the first-line approach in these subjects. The patients treated in our study, regardless of their skeletal anomalies, experienced a remarkable regression of their symptoms. Our findings suggest that the improvement in the respiratory symptoms is correlated to the increase in the SNA after surgery. This factor could help surgeons to plan surgical interventions on OSAS patients in advance, allowing them to define the amount of maxillary advancement required. Further research in a larger sample is needed to increase the predictive precision and significance of the results with a view to clinical application.
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